This study found that GPR50 expression was higher than that of other genes in CSLC-converted BC cell lines obtained from chemotherapy-treated patients, suggesting that GPR50 may be involved in breast cancer stem cell regulation. The gene discussed is GPR50; the disease is breast carcinoma.